Equivalent Lung Dose and Systemic Exposure of Budesonide/Formoterol Combination via Easyhaler and Turbuhaler

Background: Easyhaler(®) device-metered dry powder inhaler containing budesonide and formoterol fumarate dihydrate (hereafter formoterol) for the treatment of asthma and chronic obstructive pulmonary disease has been developed. The current approvals of the product in Europe were based on several pha...

Descripción completa

Detalles Bibliográficos
Autores principales: Lähelmä, Satu, Sairanen, Ulla, Haikarainen, Jussi, Korhonen, Jani, Vahteristo, Mikko, Fuhr, Rainard, Kirjavainen, Merja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4688463/
https://www.ncbi.nlm.nih.gov/pubmed/25757188
http://dx.doi.org/10.1089/jamp.2014.1195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4688463/
https://www.ncbi.nlm.nih.gov/pubmed/25757188
http://dx.doi.org/10.1089/jamp.2014.1195

Ejemplares similares